Mutations or adverse drug reactions affecting ABCB11 can result in diseases such as progressive familial intrahepatic cholestasis type 2 (PFIC2) and drug-induced cholestasis (DIC) [39,40]. The gene discussed is ABCB11; the disease is progressive familial intrahepatic cholestasis type 2.